Douglas K Bratton - Net Worth and Insider Trading
Douglas K Bratton Net Worth
The estimated net worth of Douglas K Bratton is at least $1.1 Billion dollars as of 2024-11-13. Douglas K Bratton is the 10% Owner of Juno Therapeutics Inc and owns about 9,348,799 shares of Juno Therapeutics Inc (JUNO) stock worth over $813 Million. Douglas K Bratton is the 10% Owner of Denali Therapeutics Inc and owns about 10,084,938 shares of Denali Therapeutics Inc (DNLI) stock worth over $302 Million. Douglas K Bratton is also the Director, 10% Owner of Aquestive Therapeutics Inc and owns about 2,918,081 shares of Aquestive Therapeutics Inc (AQST) stock worth over $15 Million. Details can be seen in Douglas K Bratton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas K Bratton has not made any transactions after 2021-02-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Douglas K Bratton
Douglas K Bratton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas K Bratton owns 4 companies in total, including Denali Therapeutics Inc (DNLI) , Midwest Holding Inc (MDWT) , and Aquestive Therapeutics Inc (AQST) among others .
Click here to see the complete history of Douglas K Bratton’s form 4 insider trades.
Insider Ownership Summary of Douglas K Bratton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DNLI | Denali Therapeutics Inc | 2021-02-12 | 10 percent owner |
| MDWT | Midwest Holding Inc | 2020-04-24 | director & 10 percent owner |
| AQST | Aquestive Therapeutics Inc | 2018-07-24 | director & 10 percent owner |
 | | 2017-07-13 | 10 percent owner |
Douglas K Bratton Latest Holdings Summary
Douglas K Bratton currently owns a total of 3 stocks. Among these stocks, Douglas K Bratton owns 9,348,799 shares of Juno Therapeutics Inc (JUNO) as of July 13, 2017, with a value of $813 Million and a weighting of 72%. Douglas K Bratton owns 10,084,938 shares of Denali Therapeutics Inc (DNLI) as of February 12, 2021, with a value of $302 Million and a weighting of 26.71%. Douglas K Bratton also owns 2,918,081 shares of Aquestive Therapeutics Inc (AQST) as of July 24, 2018, with a value of $15 Million and a weighting of 1.29%.
Latest Holdings of Douglas K Bratton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JUNO | Juno Therapeutics Inc | 2017-07-13 | 9,348,799 | 86.96 | 812,971,561 |
| DNLI | Denali Therapeutics Inc | 2021-02-12 | 10,084,938 | 29.90 | 301,539,646 |
| AQST | Aquestive Therapeutics Inc | 2018-07-24 | 2,918,081 | 4.99 | 14,561,224 |
Holding Weightings of Douglas K Bratton
Douglas K Bratton Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas K Bratton has made a total of 0 transactions in Juno Therapeutics Inc (JUNO) over the past 5 years. The most-recent trade in Juno Therapeutics Inc is the sale of 8,000,000 shares on July 13, 2017, which brought Douglas K Bratton around $216 Million.
According to the SEC Form 4 filings, Douglas K Bratton has made a total of 7 transactions in Denali Therapeutics Inc (DNLI) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Denali Therapeutics Inc is the sale of 2,216,798 shares on February 12, 2021, which brought Douglas K Bratton around $144 Million.
According to the SEC Form 4 filings, Douglas K Bratton has made a total of 0 transactions in Aquestive Therapeutics Inc (AQST) over the past 5 years. The most-recent trade in Aquestive Therapeutics Inc is the acquisition of 165,000 shares on July 24, 2018, which cost Douglas K Bratton around $2 Million.
Insider Trading History of Douglas K Bratton
- 1
Douglas K Bratton Trading Performance
GuruFocus tracks the stock performance after each of Douglas K Bratton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas K Bratton is 0.1%. GuruFocus also compares Douglas K Bratton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas K Bratton within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas K Bratton's insider trading performs compared to the benchmark.
Performance of Douglas K Bratton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.88 | | | | | |
| Relative Return to S&P 500(%) | -19.46 | | | | | |
Douglas K Bratton Ownership Network
Ownership Network List of Douglas K Bratton
Ownership Network Relation of Douglas K Bratton
Douglas K Bratton Owned Company Details
What does Denali Therapeutics Inc do?
Who are the key executives at Denali Therapeutics Inc?
Douglas K Bratton is the 10 percent owner of Denali Therapeutics Inc. Other key executives at Denali Therapeutics Inc include COO and Secretary Alexander O. Schuth , director & President and CEO Ryan J. Watts , and CFO and Treasurer Steve E. Krognes .
Denali Therapeutics Inc (DNLI) Insider Trades Summary
Over the past 18 months, Douglas K Bratton made no insider transaction in Denali Therapeutics Inc (DNLI). Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 29,606 shares made by Vicki L Sato , a net sale of 99,326 shares made by Alexander O. Schuth , and a net sale of 54,249 shares made by Carole Ho .
In summary, during the past 3 months, insiders sold 128,556 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 128,556 shares. During the past 18 months, 478,916 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 478,916 shares.
Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Denali Therapeutics Inc Insider Transactions
Douglas K Bratton Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas K Bratton. You might contact Douglas K Bratton via mailing address: 201 Main Street, Suite 1900, Fort Worth Tx 76102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
